PROVIDER PROFILE · NPI 1659456242

Bernard Hojaili

Internal MedicineNew Iberia, LAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

16,476

Beneficiaries

—

Total drug cost

$9.2M

Distinct drugs

Brand share

26.2%

Top prescribed drugs

Hydroxychloroquine Sulfate1,580 claims

Methotrexate Sodium1,249 claims

Gabapentin1,105 claims

Tizanidine Hcl1,021 claims

Hydrocodone/Acetaminophen1,012 claims

QUALITY · MIPS · 2024

Final MIPS score

77.6

Quality

68.9

Cost

79.1

Improvement activities

40.0

Promoting interop.

0.0

Payment adjustment

0.11%

Group

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$3K

Payment records

105

By payment type

Food and Beverage$2K

Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$700

Education$100

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history